Video Latest - ecancer

Carfilzomib represents potent, effective addition to standard multiple myeloma therapy in phase III study

Prof Keith Stewart - Mayo Clinic, Scottsdale, USA

7 Dec 2014

Post-transplant survival boosted by brentuximab vedotin in lymphoma

Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA

7 Dec 2014

Brentuximab vedotin prolongs post-transplant survival in hard-to-treat lymphoma patients in phase III study

Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Center, New York, USA

7 Dec 2014

Children with aggressive leukaemia experiencing remission with T cell therapy

Dr Stephan Grupp - The Children's Hospital of Philadelphia, Philadelphia, USA

7 Dec 2014

Overall survival update from the BREAK-3 study

Prof Axel Hauschild - University Hospital Schleswig-Holstein, Kiel, Germany

4 Dec 2014

Frontiers of pharmacokinetics and metabolism in cancer research

Prof Godefridus Peters - VU University Medical Center, Amsterdam, Netherlands

1 Dec 2014

ecancermedicalscience editor's choice for November 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

28 Nov 2014

Overcoming cancer resistance with enzyme inhibitors

Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden

27 Nov 2014

New emerging treatments and challenges in MCL, MM and CLL: Expert panel discussion

Prof Simon Rule, Dr Maria-Victoria Mateos, Prof Paolo Ghia, Prof Antonio Palumbo

24 Nov 2014

Cancer genomics and pancreatic cancer

Prof Andrew Biankin - University of Glasgow, Glasgow, UK

11 Nov 2014

Fly models and genome sequencing

Dr Ross Cagan - Mount Sinai School of Medicine, New York, USA

11 Nov 2014

Comment: NCRI 2014 conference – Highlights and the future

Prof Richard Marais - Director of the Cancer Research UK Manchester Institute, Manchester, UK

10 Nov 2014

Video